Preparation process of gynecological Zhixueling capsules

Abstract

The invention discloses a preparation process of gynecological Zhixueling capsules. The Zhixueling capsules are prepared from the following raw materials in parts by weight of prepared rehmannia roots, Chinese magnoliavine fruits, teasel roots, eucommia bark (charcoal), white paeony roots, Chinese yams, oysters (calcined), cuttlebones, sanguisorba officinalis (fried), pollen typhae (charcoal) andmistletoe. The preparation process comprises the steps of crushing the cuttlebones, the Chinese yams and the pollen typhae (charcoal), and performing sieving with an 80-mesh sieve for later use; putting the prepared rehmannia roots, the Chinese magnoliavine fruits, the eucommia bark (charcoal), the teasel roots, the white paeony roots, the oysters (calcined), the sanguisorba officinalis (fried) and the mistletoe into an extraction tank of 3m < 3 >, performing decocting twice, combining decoctions, performing filtering, and concentrating filtrate into thick paste for later use; and uniformly mixing powder with the thick paste, performing vacuum drying, performing crushing, performing sieving with an 80-mesh sieve, performing uniform mixing with starch, adding ethanol to prepare granules, performing drying, and performing encapsulating to prepare 1000 granules, so that the product is obtained. The Zhixueling capsules have the effects of cooling blood, regulating menstruation, tonifying kidney, removing stasis, nourishing blood and promoting astringing, and are remarkable in curative effect on functional uterine bleeding, high in cure rate and free of toxic and side effects.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a preparation process of Fuke Zhixueling Capsules. Background technique [0002] In the prior art, functional uterine bleeding, also known as uterine blood, is caused by neuroendocrine disorders, rather than pregnancy, endometrial tumors, infection or blood diseases. The drugs currently used for hemostasis are mainly hormonal drugs, which are divided into progestins, estrogens and androgens. When progesterone is used for hemostasis, progesterone supplementation can transform the endometrium in the proliferative phase or hyperplasia into the secretory phase, and the endometrium will fall off after stopping the drug, leading to drug withdrawal bleeding. Because this kind of endometrial shedding is more complete, it is also called "drug-induced curettage". It is suitable for patients who already have a certain level of estrogen in the body. Whe...

AI Technical Summary

Problems solved by technology

When using androgen for hemostasis, androgen cannot immediately change the process of endometrium shedding in the event of massive bleeding, nor can it make it repair quickly, and the effect of single application is not good

However, the defects in the use of hormonal drugs are relatively obvious. Often, the drug cannot be stopped immediately, and the dosage needs to be gradually reduced until the use is stopped. At the same time, drug withdrawal bleeding is also prone to occur.